Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Health Technology Assessment in the UK.

Literature DB >> 24120204

Health Technology Assessment in the UK.

Abstract

In this Review, we discuss the UK's Health Technology Assessment programme, which is 20 years old in 2013. We situate the programme in the context of the UK landscape for evidence-based medicine, including in relation to the National Institute for Health and Care Excellence and as guidance to the National Health Service. We identify features that might be of value to other health systems as they confront the challenges of rapid innovation and rising costs. We use examples of recent studies to show the strengths and weaknesses of the programme.

Mesh：

Year: 2013 PMID： 24120204 DOI： 10.1016/S0140-6736(13)61724-9

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

12 in total

Review 1. Next-generation multiple myeloma treatment: a pharmacoeconomic perspective.

Authors: S Vincent Rajkumar; Jean Luc Harousseau
Journal: Blood Date: 2016-10-14 Impact factor: 22.113

2. Rational prescribing: the principles of drug selection.

Authors: Simon Rj Maxwell
Journal: Clin Med (Lond) Date: 2016-10 Impact factor: 2.659

3. Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols.

Authors: Derek Kyte; Helen Duffy; Benjamin Fletcher; Adrian Gheorghe; Rebecca Mercieca-Bebber; Madeleine King; Heather Draper; Jonathan Ives; Michael Brundage; Jane Blazeby; Melanie Calvert
Journal: PLoS One Date: 2014-10-15 Impact factor: 3.240

4. The DiReCT study - improving recruitment into clinical trials: a mixed methods study investigating the ethical acceptability, feasibility and recruitment yield of the cohort multiple randomised controlled trials design.

Authors: David A Richards; Sarah Ross; Sarah Robens; Gunilla Borglin
Journal: Trials Date: 2014-10-16 Impact factor: 2.279

5. Do reimbursement recommendation processes used by government drug plans in Canada adhere to good governance principles?

Authors: Nigel Sb Rawson; John Adams
Journal: Clinicoecon Outcomes Res Date: 2017-11-22

10. Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations.

Authors: Tania Yuka Yuba; Hillegonda Maria Dutilh Novaes; Patrícia Coelho de Soárez
Journal: Health Res Policy Syst Date: 2018-05-11

Health Technology Assessment in the UK.

Review 1. Next-generation multiple myeloma treatment: a pharmacoeconomic perspective.

2. Rational prescribing: the principles of drug selection.

3. Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols.

4. The DiReCT study - improving recruitment into clinical trials: a mixed methods study investigating the ethical acceptability, feasibility and recruitment yield of the cohort multiple randomised controlled trials design.

5. Do reimbursement recommendation processes used by government drug plans in Canada adhere to good governance principles?

6. Do health apps need endorsement? Challenges for giving advice about which health apps are safe and effective to use.

7. Application of Discrete Choice Experiment in Health Care: A Bibliometric Analysis.

8. The clinical relevance and newsworthiness of NIHR HTA-funded research: a cohort study.

Review 9. The importance of values in evidence-based medicine.

10. Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations.